Literature DB >> 4624760

Early extracellular events in infection of competent Bacillus subtilis by DNA of bacteriophage SP82G.

G L Williams, D M Green.   

Abstract

Analysis, by the recovery of specific genetic "markers," of the effects of DNase I, physical shear, and temperature shock on DNA-cell complexes demonstrates that sequential attachment of both ends of bacteriophage SP82G DNA to Bacillus subtilis precedes entry of the DNA molecule into the cell, and that each attachment is end-and time-specific. The first attachment involves an initial reversible phase, followed by irreversible binding. After a latent period, the second end then attaches to the cell. Entry of the molecule begins immediately after binding of the second end has occurred, and entry is complete within 3 min. The polarity of entry, as judged by attainment of resistance to DNase I, is the reverse of that observed in normal phage injection.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4624760      PMCID: PMC426745          DOI: 10.1073/pnas.69.6.1545

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

1.  A NOVEL METHOD FOR THE RELEASE OF BACTERIOPHAGE DNA.

Authors:  D FREIFELDER
Journal:  Biochem Biophys Res Commun       Date:  1965-01-04       Impact factor: 3.575

2.  Genetic activity of deoxyribonucleic acid in the reconstitution of biosynthetic pathways.

Authors:  J SPIZIZEN
Journal:  Fed Proc       Date:  1959-12

3.  Linkage of genetic units of Bacillus subtilis in DNA transformation.

Authors:  E W NESTER; J LEDERBERG
Journal:  Proc Natl Acad Sci U S A       Date:  1961-01-15       Impact factor: 11.205

4.  Manifestation of linear organization in molecules of pneumococcal transforming DNA.

Authors:  M Gabor; R D Hotchkiss
Journal:  Proc Natl Acad Sci U S A       Date:  1966-11       Impact factor: 11.205

5.  A genetic study of temperature-sensitive mutants of the subtilis phage SP82.

Authors:  E Kahan
Journal:  Virology       Date:  1966-12       Impact factor: 3.616

6.  Fate of transforming DNA following uptake by competent Bacillus subtilis. IV. The endwise attachment and uptake of transforming DNA.

Authors:  D Dubnau; C Cirigliano
Journal:  J Mol Biol       Date:  1972-02-28       Impact factor: 5.469

7.  Bacteriophage infection: which end of the SP82G genome goes in first?

Authors:  W T McAllister
Journal:  J Virol       Date:  1970-02       Impact factor: 5.103

8.  Early energy-dependent step in the entry of transforming deoxyribonucleic acid.

Authors:  N Strauss
Journal:  J Bacteriol       Date:  1970-01       Impact factor: 3.490

9.  LAG PERIOD CHARACTERIZING THE ENTRY OF TRANSFORMING DEOXYRIBONUCLEIC ACID INTO BACILLUS SUBTILIS.

Authors:  J S LEVINE; N STRAUSS
Journal:  J Bacteriol       Date:  1965-02       Impact factor: 3.490

10.  CONFIGURATION OF TRANSFORMING DEOXYRIBONUCLEIC ACID DURING ENTRY INTO BACILLUS SUBTILIS.

Authors:  N STRAUSS
Journal:  J Bacteriol       Date:  1965-02       Impact factor: 3.490

View more
  5 in total

1.  Deoxyribonucleic acid-membrane complexes in the Bacillus subtilis transformation system.

Authors:  D C Dooley; E W Nester
Journal:  J Bacteriol       Date:  1973-05       Impact factor: 3.490

Review 2.  Bacteriophages of Bacillus subtilis.

Authors:  H E Hemphill; H R Whiteley
Journal:  Bacteriol Rev       Date:  1975-09

3.  Early stages in DNA binding and uptake during genetic transformation of pneumococci.

Authors:  H Seto; A Tomasz
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

4.  Temperate Bacillus subtilis bacteriophage phi 3T: chromosomal attachment site and comparison with temperate bacteriophages phi 105 and SPO2.

Authors:  M T Williams; F E Young
Journal:  J Virol       Date:  1977-02       Impact factor: 5.103

5.  Protease-sensitive transfection of Bacillus subtilis with bacteriophage GA-1 DNA: a probable case of heterologous transfection.

Authors:  F Arwert; G Venema
Journal:  J Virol       Date:  1974-03       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.